• The use of master protocols and a platform design: lessons from COVID-19 therapeutic trials
• A platform trial and master protocol for PAH clinical trials: is it feasible, and if so, which drugs do we want to study?
• The use of RWD/RWE in bringing drugs to PH patients
• RWD/RWE in PH: what are the questions and can we get the answers?

The use of master protocols and a platform design: lessons from COVID-19 therapeutic trials

14:00-14:15 BST

Presenter: // Lisa Lavange, University of North Carolina, USA

A platform trial and master protocol for PAH clinical trials: is it feasible, and if so, which drugs do we want to study?

14:15-14:30 BST

Panel discussion: // Ardeschir Ghofrani, Roham Zamanian, CQ Deng & Mardi Gomberg-Maitland

The use of RWD/RWE in bringing drugs to PH patients

14:30-14:45 BST

Presenter: // Steve Mathai, Johns Hopkins University, USA

RWD/RWE in PH: what are the questions and can we get the answers?

14:45-15:00 BST

Panel discussion: //